Cellbricks

What does it take to create Europe's next globally leading biotech ecosystem, covering every step from groundbreaking research to successful commercialisation? This was the leading question at this year’s fireside panel discussion at the #DRFZBerlinSymposium2024.     Key takeaways from the panel discussion: Strong Consensus: Europe has the huge potential conducting groundbreaking research.      Issue: A significant gap exists in translating research from the lab to the clinic, especially due to complex regulatory frameworks.      Recommendation: Policymakers must simplify regulatory frameworks and provide clearer guidance to accelerate the path of new therapies to patients.     Thanks for this great exchange between our Joachim von Arnim and Eicke Latz (German Rheumatology Research Center) | Stefan Miltenyi (Miltenyi Biotec) | Luke O'Neill (Trinity College Dublin) | Jan-Philipp Kruse (Bayer) | Dr. Thorsten Lambertus (DEEP - ESMT Berlin) as well as moderator Marco Janezic (Blue Ribbon Partners)     #TissueTherapeutics #Cellbricks #Charité #MaxPlanckSociety #Ecosystem 

An exciting week ahead: Cellbricks will be presenting at #TERMIS2024 World Congress in Seattle from June 25-28! Join us for our poster presentation on light-based 3D-bioprinting of vascularised fatty tissue for breast reconstruction. Léa Pourchet, Ph.D., our Senior Tissue Engineer, is eager to connect with you and share our latest advancements in tissue therapeutics. Details: Poster session III, C1, Thursday, June 27 We are looking forward to lively discussions! #TERMIS2024 #RegenerativeMedicine #TissueEngineering #3DBioprinting #Cellbricks #TissueTherapeutics

We're hiring – SENIOR LIVER CELL BIOLOGIST! #JoinOurTeam Cellbricks seeks an experienced liver cell biologist to join our Liver Tissue Therapeutics Program. In this role, you'll pioneer methods for scalable liver cell delivery and integrate them into our 3D-bioprinted constructs. Be a part of our mission to revolutionise the lives of millions with compromised organ function by advancing biofabricated tissue therapeutics. Help us enable longer and healthier lives of everyone. Ready to make a difference and for an exciting career step? Apply here: https://lnkd.in/eXNiWcue Let's create something extraordinary together! #JoinOurTeam #NowHiring #Cellbricks #JobOpening #3DBioprinting #Liver #OrganTransplantation #TissueTherapeutics

Meet us at BIO International Convention 2024 in San Diego.    Our CEO, Alexander Leutner, and COO, Dr. Simon MacKenzie, will attend the conference to talk about our life-saving tissue therapeutics and build collaborations.     Who else is going, do you fancy a meeting? Please reach out directly or go through the partnering platform. We are looking forward to seeing you on-site! #BIO2024 #TissueTherapeutics #Cellbricks #Biotech #RegenerativeMedicine #BioInternationalConvention

The Dutch Regenerative Medicine Innovation Mission visited Cellbricks to get insights and discuss our tissue therapeutics and light-based 3D-bioprinting platform. Many thanks for the visit and the lively talks. A delegation of representatives from Dutch Regmed organisations travelled to Germany to scout for industry trends and to explore partnership opportunities with companies and institutes as part of the innovation mission of Dutch-German regenerative medicine collaborations. The joint goal of this mission is to bring ground-breaking regenerative medicine treatments to market and enhance patients' quality of life. We are proud to support this mission by producing live-saving tissue therapeutics so that humans can enjoy longer and healthier lives. This innovation mission has been focusing on the Berlin and Munich ecosystems, with stops at the Berlin Institute of Health | chariteberlin | Max Delbrück Center | Cellbricks | Helmholtz Pioneer Campus @ Helmholtz Munich and networking opportunities with Fraunhofer IPA | Fraunhofer TLZ-RT and BioM Biotech Cluster Development GmbH. Big shout to Netherlands Enterprise Agency and Netherlands Innovation Network Germany to develop the mission program in collaboration with RegMed XB and Health~Holland. Thank you for considering us amongst this unique selection of innovative players in the space. Cellbricks is happy to be part of the program and proud of the new connections and friends made: Basic Pharma - Pascal Simoens | BioMiMattInk - Ivo Beeren | UGent - An Van Den Bulcke, Sandra. Van Vlierberghe | Innovation Center for Advanced Therapies (ICAT) - Joost van Duijn, Karel Loerts | Leiden University Medical Center - Hanna Lammertse, PhD | NecstGen - Sophia Kolbe | RegMed XB - Bernard Mulder, Frank Luyten, Lena Wijnen | Scinus Cell Expansion B.V. - Ralf Heijkants | Smart BioMaterials Consortium (SBMC) - Juliette van den Dolder | Eindhoven University of Technology - Harmen de Jongh | Netherlands Heart Institute | Universitair Medisch Centrum Utrecht - Pieter Doevendans We are looking forward to the follow-ups. Let's boost the regenerative medicine space together! #Cellbricks #TissueTherapeutics #NetherlandsEnterpriseAgency #DutchGermanCollaboration #RegenerativeMedicine

Three weeks, three events & three stages: many new connections. Our management team was presenting our vision of the future of live-saving tissue therapeutics at various occasions. Many thanks to the hosts for having us. Here are some impressions from the past events.  MassBio’s Align Summit, Boston | Dr. Simon MacKenzie, COO Fantastic panel discussions, presentations from seed & series A Biotechs and valuable networking opportunities. Looks like we'll be in town more often. Venture SPRIND, Berlin | Joachim von Arnim, CSO Our supporters at The Federal Agency for Disruptive Innovation (SPRIND - Bundesagentur für Sprunginnovationen) back start-ups developing ground-breaking technologies that can create major impact on society and economy. Over 60 teams from the Deep Tech, Biotech and Life Science sectors presented their solutions.   Forever Healthy’s Rejuvenation Summit, Berlin | Alexander Leutner, CEO World’s largest gathering of longevity startups bringing together biotechs, members of the longevity venture capital & investor ecosystem, and researchers – all with the goal of accelerating the development of the rejuvenation biotech industry. #TissueTherapeutics #Cellbricks #AlignSummit24 #VentureSprind #RejuvenationStartupSummit    

Please join us in welcoming four new tissue engineers to Cellbricks driving forward our groundbreaking work in liver and soft tissue therapeutics. Left to right: Léa Pourchet, Ph.D. | Marta Maciel, PhD | Alicia Ruppelt | Flora Guarnotta. We are incredibly happy to have you on board! Do you want to become part of our great and dynamic team dedicated to making a real difference in healthcare and shaping the future of regenerative medicine? Check out our open positions (Laboratory Assistant, Mechatronics Engineer and many more) here: https://lnkd.in/eXNiWcue #WelcomeToTheTeam #Cellbricks #TissueTherapeutics #RegenerativeMedicine #JoinOurTeam 

Join us at MassBio's 2024 Align Summit to hear from our COO, Dr. Simon MacKenzie, as he discusses Cellbricks life-saving tissue therapeutics. This event on April 25 features exciting pitches from fellow innovative startups and insightful sessions led by McKinsey & Company and Locust Walk. Don't miss out on a full day of panel discussions, presentations from seed & series A biotechs, and valuable networking opportunities. For scheduling a meeting, please drop Simon a line. You can also register here: https://lnkd.in/euynZvkA Date and time: April 25, 2024 from 11:15 am – 11:35 am   Location: Longfellow (West Tower) (40 Edwin H Land Blvd, Cambridge, MA 02142)  #AlignSummit24 #Cellbricks #TissueTherapeutics #BiotechNetworking 

Exciting leadership updates at Cellbricks!    We are thrilled to introduce Dr. Simon MacKenzie, our new Chief Operating Officer, driving our tissue therapeutic programs. With over 30 years of experience in business, pharma, biotech and 3D-bioprinting across the globe, Simon, you are perfectly positioned to lead our therapeutic initiatives.   At the same time, we extend our deepest gratitude to our visionary founder, Dr. Lutz Kloke, the genius behind light-based, multi-material 3D-Bioprinting. Lutz, welcome to our board of advisors! Your invaluable contribution has paved the way for tissue therapeutics. We are honored to have your ongoing support.   Full speed ahead: With our combined scientific force of Cellbricks co-founders Dr. Tobias Lam & Alexander Thomas, alongside Dr. Anna-Klara Amler and the dynamic leadership team comprising Alexander Leutner, Joachim von Arnim, and Simon MacKenzie, Cellbricks is on the brink of revolutionary breakthroughs in regenerative medicine. Together with our dedicated team, new members joining and our partners, we are determined to advance tissue therapeutics towards clinical success and put a dent in the universe.   #TissueTherapeutics #Cellbricks #Keyhire #Transition #FullSpeedAhead #ReplicatingHumanTissueAtScale

One step closer to delivering liver tissue therapeutics to patients. SPRIND - Bundesagentur für Sprunginnovationen, Germany's Federal Agency for Disruptive Innovation, supports us in developing liver tissue therapeutics so that patients dealing with seriously impaired liver function can enjoy longer and healthier lives. Together with our clinical partners at CHARITE UNIVERSITATSMEDIZIN BERLIN, we have set ourselves the goal to replicate human liver tissue at scale. We will use 3D bioprinting to biofabricate human liver tissue that will ultimately be implanted into the patients' bodies. We are proud to make a major contribution to alleviate the global liver crisis and to have won SPRIND-Bundesagententur für Sprunginnovationen as a partner for this exciting journey.    About SPRIND - Bundesagentur für Sprunginnovationen    SPRIND invests in groundbreaking projects that shape the future and provide answers to the most pressing social, ecological and economic challenges of our time. The goal is to create new leapfrogging innovations made in Germany. In other words, products, services and systems that make our lives noticeably and sustainably better.  “Funke Tissue Engineering” is the latest innovation challenge by SPRIND and scouts for solutions that target the global organ shortage by creating artificial organ tissue.     #SPRIND #Cellbricks #Charité #FunkeTissueEngineering #ReplicatingHumanTissueAtScale #OrganCrisis #Longevity #TissueTherapeutics #3DBioprinting